title: Pharmacokinetics of an antifibrotic agent, pirfenidone, in haemodialysis patients.
authors.forename: M
authors.initials: M
authors.lastname: Taniyama
authors.forename: S
authors.initials: S
authors.lastname: Ohbayashi
authors.forename: M
authors.initials: M
authors.lastname: Narita
authors.forename: R
authors.initials: R
authors.lastname: Nakazawa
authors.forename: S
authors.initials: S
authors.lastname: Hasegawa
authors.forename: N
authors.initials: N
authors.lastname: Azuma
authors.forename: S
authors.initials: S
authors.lastname: Teraoka
authors.forename: K
authors.initials: K
authors.lastname: Ota
authors.forename: S
authors.initials: S
authors.lastname: Yamauchi
authors.forename: S B
authors.initials: SB
authors.lastname: Margolin
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D005260:Female; D005355:Fibrosis / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011728:Pyridones / Q000493:pharmacokinetics*; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D011728:Pyridones; C093844:pirfenidone